Baron Silver Stevens Financial Advisors, LLC Gilead Sciences, Inc. Transaction History
Baron Silver Stevens Financial Advisors, LLC
- $674 Million
- Q3 2025
A detailed history of Baron Silver Stevens Financial Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baron Silver Stevens Financial Advisors, LLC holds 7,024 shares of GILD stock, worth $871,608. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,024
Previous 7,077
0.75%
Holding current value
$871,608
Previous $784,000
0.64%
% of portfolio
0.12%
Previous 0.13%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...